Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Sep 21, 2018
Financial News
Ex-Kite execs prep quick IPO for CAR T play Allogene
...EU. In addition to Chang and Belldegrun, Allogene's nine-member board includes four former Kite directors:
David Bonderman
...
Read More
BioCentury
|
Sep 14, 2018
Financial News
Ex-Kite execs prep quick IPO for CAR T play Allogene
...EU. In addition to Chang and Belldegrun, Allogene's nine-member board includes four former Kite directors:
David Bonderman
...
Read More
BioCentury
|
Feb 4, 2013
Emerging Company Profile
Kite: Immune system rewrite
...dosing. Kite raised $15 million in a March 2011 seed round led by individual investor
David Bonderman
...
Read More
BioCentury
|
Mar 14, 2011
Company News
Kite Pharma board of directors update
...Kite Pharma Inc. , Los Angeles, Calif. Business: Cancer Appointed:
David Bonderman
, founding partner of TPG Capital WIR...
Read More
BioCentury
|
Mar 10, 2011
Financial News
Kite raises $15M in seed round
...Inc. (Los Angeles, Calif.) raised $15 million in a seed round led by individual investor
David Bonderman
...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
Sep 21, 2018
Financial News
Ex-Kite execs prep quick IPO for CAR T play Allogene
...EU. In addition to Chang and Belldegrun, Allogene's nine-member board includes four former Kite directors:
David Bonderman
...
Read More
BioCentury
|
Sep 14, 2018
Financial News
Ex-Kite execs prep quick IPO for CAR T play Allogene
...EU. In addition to Chang and Belldegrun, Allogene's nine-member board includes four former Kite directors:
David Bonderman
...
Read More
BioCentury
|
Feb 4, 2013
Emerging Company Profile
Kite: Immune system rewrite
...dosing. Kite raised $15 million in a March 2011 seed round led by individual investor
David Bonderman
...
Read More
BioCentury
|
Mar 14, 2011
Company News
Kite Pharma board of directors update
...Kite Pharma Inc. , Los Angeles, Calif. Business: Cancer Appointed:
David Bonderman
, founding partner of TPG Capital WIR...
Read More
BioCentury
|
Mar 10, 2011
Financial News
Kite raises $15M in seed round
...Inc. (Los Angeles, Calif.) raised $15 million in a seed round led by individual investor
David Bonderman
...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page